FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+7.59%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$8.79B
AUM Growth
+$8.79B
(+8.4%)
Cap. Flow
+$363M
Cap. Flow
% of AUM
4.13%
Top 10 Holdings %
Top 10 Hldgs %
51.77%
Holding
99
New
29
Increased
20
Reduced
18
Closed
19
Top Buys
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$677M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$463M |
| 3 |
MBLY
Mobileye N.V.
MBLY
|
$257M |
| 4 |
NXP Semiconductors
NXPI
|
$166M |
| 5 |
Huntsman Corp
HUN
|
$140M |
Top Sells
| 1 |
YHOO
Yahoo Inc
YHOO
|
$463M |
| 2 |
BEAV
B/E Aerospace Inc
BEAV
|
$322M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
$319M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
$205M |
| 5 |
Eli Lilly
LLY
|
$134M |
Sector Composition
| 1 | Technology | 27.51% |
| 2 | Communication Services | 23.99% |
| 3 | Healthcare | 13.79% |
| 4 | Industrials | 6.24% |
| 5 | Consumer Discretionary | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKAO
51
DELISTED
Achaogen, Inc.
AKAO
| $20.6M | 0.21% | 948,500 +131,000 | +16% | +$2.85M |
|
52
AstraZeneca
AZN
$248B
| $19.6M | 0.2% | 575,000 -577,500 | -50% | -$19.7M |
|
53
Puma Biotechnology
PBYI
$254M
| $18.6M | 0.19% | 213,000 -367,500 | -63% | -$32.1M |
|
|
SHPG
54
DELISTED
Shire pic
SHPG
| $17.9M | 0.19% | +108,500 | New | +$17.9M |
|
|
NVET
55
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $17.7M | 0.18% | 2,648,696 | – | – |
|
56
Alnylam Pharmaceuticals
ALNY
$58.5B
| $16M | 0.17% | +200,000 | New | +$16M |
|
57
Hyatt Hotels
H
$13.8B
| $14.9M | 0.15% | 265,000 -349,000 | -57% | -$19.6M |
|
58
Savara
SVRA
$567M
| $13.1M | 0.14% | +2,225,000 | New | +$13.1M |
|
|
RXDX
59
DELISTED
Ignyta, Inc.
RXDX
| $11.9M | 0.12% | +1,153,500 | New | +$11.9M |
|
|
STML
60
DELISTED
Stemline Therapeutics, Inc.
STML
| $10.6M | 0.11% | 1,157,500 -10,000 | -0.9% | -$92K |
|
61
Akebia Therapeutics
AKBA
$833M
| $10.5M | 0.11% | +730,000 | New | +$10.5M |
|
|
WGL
62
DELISTED
Wgl Holdings
WGL
| $10M | 0.1% | +120,000 | New | +$10M |
|
|
KATE
63
DELISTED
Kate Spade & Company
KATE
| $9.8M | 0.1% | 530,000 +320,000 | +152% | +$5.92M |
|
64
TEGNA Inc
TGNA
$3.41B
| $9.66M | 0.1% | +670,000 | New | +$9.66M |
|
|
HZNP
65
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.84M | 0.09% | 745,000 -1,650,000 | -69% | -$19.6M |
|
|
SAGE
66
DELISTED
Sage Therapeutics
SAGE
| $7.96M | 0.08% | +100,000 | New | +$7.96M |
|
|
CYOU
67
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $6.23M | 0.06% | +160,812 | New | +$6.23M |
|
|
AMRN
68
Amarin Corp
AMRN
$311M
| $6.03M | 0.06% | 1,495,000 | – | – |
|
|
PCO
69
DELISTED
Pendrell Corporation - Class A
PCO
| $5.94M | 0.06% | 821,061 | – | – |
|
70
Brookdale Senior Living
BKD
$1.83B
| $4.85M | 0.05% | +330,000 | New | +$4.85M |
|
71
Qualcomm
QCOM
$173B
| $4.69M | 0.05% | +85,000 | New | +$4.69M |
|
|
IMGN
72
DELISTED
Immunogen Inc
IMGN
| $3.59M | 0.04% | +505,000 | New | +$3.59M |
|
|
GCVRZ
73
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $2.6M | 0.03% | 6,827,805 | – | – |
|
|
ZGNX
74
DELISTED
Zogenix, Inc.
ZGNX
| $2.54M | 0.03% | +175,000 | New | +$2.54M |
|
75
Forte Biosciences
FBRX
$137M
| $1.2M | 0.01% | +100,000 | New | +$1.2M |
|